ArticleBriefings in bioinformatics2025
DA-HGL: a domain-augmented heterogeneous graph learning framework for protein function prediction.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate protein function prediction is critical for deciphering disease mechanisms and advancing precision medicine, yet remains challenging for proteins with sparse annotations. Traditional methods struggle with annotation sparsity and fail to integrate multimodal data holistically. We propose DA-HGL, a heterogeneous graph learning framework that integrates protein sequences, domain architectures, and Gene Ontology (GO) hierarchies through a multilayered graph and non-negative matrix factorization with dual biological constraints. DA-HGL uniquely models domain-function coherence, GO semantic consistency, and topological congruence. Evaluated on yeast and human proteomes, DA-HGL achieves Fmax gains of 9.0% (yeast CC) and 17.2% (human BP) over state-of-the-art methods. By dynamically learning domain-context associations and resolving annotation sparsity, DA-HGL excels in cold-start scenarios and disease-specific predictions (e.g. Parkinson's "ubiquitin-dependent catabolism"). This framework offers a robust tool for accelerating functional genomics and precision medicine. Code/data: https://github.com/husaiccsu/DA-HGL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.